You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery
|
---|---|
Published in |
Cell Stem Cell, June 2023
|
DOI | 10.1016/j.stem.2023.04.017 |
Pubmed ID | |
Authors |
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chris Kato, Shiho Nakamura, Fumiko Ozawa, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Tosho Kondo, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara, The Pooled Resource Open-Access ALS Clinical Trials Consortium, Hideyuki Okano |
X Demographics
The data shown below were collected from the profiles of 69 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 13 | 19% |
Japan | 6 | 9% |
Australia | 4 | 6% |
United Kingdom | 4 | 6% |
Canada | 2 | 3% |
France | 2 | 3% |
Belgium | 1 | 1% |
Spain | 1 | 1% |
Ukraine | 1 | 1% |
Other | 3 | 4% |
Unknown | 32 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 49 | 71% |
Scientists | 14 | 20% |
Practitioners (doctors, other healthcare professionals) | 5 | 7% |
Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 52 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 13% |
Student > Ph. D. Student | 6 | 12% |
Unspecified | 4 | 8% |
Other | 3 | 6% |
Student > Bachelor | 3 | 6% |
Other | 4 | 8% |
Unknown | 25 | 48% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 8 | 15% |
Biochemistry, Genetics and Molecular Biology | 8 | 15% |
Unspecified | 4 | 8% |
Nursing and Health Professions | 3 | 6% |
Medicine and Dentistry | 2 | 4% |
Other | 5 | 10% |
Unknown | 22 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 376. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2024.
All research outputs
#84,521
of 25,726,194 outputs
Outputs from Cell Stem Cell
#49
of 2,849 outputs
Outputs of similar age
#2,015
of 391,645 outputs
Outputs of similar age from Cell Stem Cell
#1
of 42 outputs
Altmetric has tracked 25,726,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,849 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 48.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 391,645 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.